Skip to primary navigation Skip to main content
0 item $0.00

  1. Abbott AL. Carotid surgery or stenting following neck irradiation: time to address the assumptions. Eur J Vasc Endovasc Surg 2012;43(1):8-9. Comment.
  2. Abbott AL, Adelman MA, Alexandrov AV, Barnett HJ, Beard J, Bell P, Björck M, Blacker D, Buckley CJ, Cambria RP, Comerota AJ, Sander Connolly E, Davies AH, Eckstein HH, Faruqi R, Fraedrich G, Gloviczki P, Hankey GJ, Harbaugh RE, Heldenberg E, Kittner SJ, Kleinig TJ, Mikhailidis DP, Moore WS, Naylor R, Nicolaides A, Paraskevas KI, Pelz DM, Prichard JW, Purdie G, Ricco JB, Riles T, Rothwell P, Sandercock P, Sillesen H, David Spence J, Spinelli F, Tan A, Thapar A, Veith FJ, Zhou W. Why the United States Center for Medicare and Medicaid Services (CMS) should not extend reimbursement indications for carotid artery angioplasty/stenting. Vascular 2012;20(1):1-7. Eur J Vasc Endovasc Surg 2012;43(3):247-51. Int Angiol 2012;31(1):85-9. Brain Behav 2012;2(2):200-7. International multispecialty review and policy advisory statement.
  3. Abdullah A, Wolfe R, Mannan H, Stoelwinder JU, Stevenson C, Peeters A. Epidemiologic merit of obese-years, the combination of degree and duration of obesity. Am J Epidemiol 2012;176(2):99-107.
  4. Ahrens I, Peter K, Lip GY, Bode C. Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugs. Discov Med 2012;13(73):433-43. Review.
  5. Ahrens I, Peter K, Lip GY, Bode C. Development and clinical applications of novel oral anticoagulants. Part II. Drugs under clinical investigation. Discov Med 2012;13(73):445-50. Review.
  6. Allen TL, Whitham M, Febbraio MA. IL-6 muscles in on the gut and pancreas to enhance insulin secretion. Cell Metab 2012;15(1):8-9. Review.
  7. Allender S, Gleeson E, Crammond B, Sacks G, Lawrence M, Peeters A, Loff B, Swinburn B. Policy change to create supportive environments for physical activity and healthy eating: which options are the most realistic for local government? Health Promot Int 2012;27(2):261-74.
  8. Altmann DR, Ullmer E, Rickli H, Maeder MT, Sticherling C, Schaer BA, Osswald S, Ammann P. Clinical impact of screening for sleep related breathing disorders in atrial fibrillation. Int J Cardiol 2012;154(3):256-8.
  9. Anand SS, Dagenais GR, Mohan V, Diaz R, Probstfield J, Freeman R, Shaw J, Lanas F, Avezum A, Budaj A, Jung H, Desai D, Bosch J, Yusuf S, Gerstein HC. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study. Eur J Cardiovasc Prev Rehabil 2012;19(4):755-64.
  10. Armitage JA, Burke SL, Prior LJ, Barzel B, Eikelis N, Lim K, Head GA. Rapid onset of renal sympathetic nerve activation in rabbits fed a high-fat diet. Hypertension 2012;60:163-71.
  11. Armstrong PC, Hu H, Rivera J, Rigby S, Chen YC, Howden BP, Gardiner E, Peter K. Staphylococcal superantigen-like protein 5 induces thrombotic and bleeding complications in vivo: inhibition by an anti-SSL5 antibody and the glycan Bimosiamose. J Thromb Haemost 2012;10(12):2607-9. Letter.
  12. Armstrong PC, Peter K. GPIIb/IIIa inhibitors: from bench to bedside and back to bench again. Thromb Haemost 2012;107(5):808-14. Review.
  13. Azzopardi P. The art of medicine: adolescent health comes of age. Lancet 2012;379(9826):1583-4. Comment.
  14. Azzopardi P, Brown AD, Zimmet P, Fahy RE, Dent GA, Kelly MJ, Kranzusch K, Maple-Brown LJ, Nossar V, Silink M, Sinha AK, Stone ML, Wren SJ. Type 2 diabetes in young Indigenous Australians in rural and remote areas: diagnosis, screening, management and prevention. Med J Aust 2012;197(1):32-6. Guidelines.
  15. Backholer K, Chen L, Shaw J. Screening for diabetes. Pathology 2012;44(2):110-4. Review.
  16. Backholer K, Freak-Poli R, Peeters A. Daily step-count and change in waist circumference during a workplace pedometer program. Open J Prev Med 2012;2(2):249-56.
  17. Backholer K, Mannan HR, Magliano DJ, Walls HL, Stevenson C, Beauchamp A, Shaw JE, Peeters A. Projected socioeconomic disparities in the prevalence of obesity among Australian adults. Aust N Z J Public Health 2012;36(6):557-63.
  18. Backholer K, Pasupathi K, Wong E, Hodge A, Stevenson C, Peeters A. The relationship between body mass index prior to old age and disability in old age. Int J Obes 2012;36(9):1180-6.
  19. Backholer K, Peeters A. Reduction of trans-fatty acids from food. JAMA 2012;308(18):1858-9. Letter.
  20. Backholer K, Wong E, Freak-Poli R, Walls HL, Peeters A. Increasing body weight and risk of limitations in activities of daily living: a systematic review and meta-analysis. Obes Rev 2012;13(5):456-68. Review.
  21. Barber MN, Risis S, Yang C, Meikle PJ, Staples M, Febbraio MA, Bruce CR. Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS One 2012;7(7):e41456.
  22. Baskerville CA, Hanrahan BB, Burke AJ, Holwell AJ, Rémond MG, Maguire GP. Infective endocarditis and rheumatic heart disease in the north of Australia. Heart Lung Circ 2012;21(1):36-41.
  23. Bayles R, Kn H, Lambert E, Baker EK, Agrotis A, Guo L, Jowett JB, Esler M, Lambert G, El-Osta A. Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome. Arterioscler Thromb Vasc Biol 2012;32(8):1910-6.
  24. Bernardi S, Burns WC, Toffoli B, Pickering R, Sakoda M, Tsorotes D, Grixti E, Velkoska E, Burrell LM, Johnston C, Thomas MC, Fabris B, Tikellis C. Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7). Clin Sci 2012;123(1):29-37.
  25. Bernardi S, Toffoli B, Zennaro C, Tikellis C, Monticone S, Losurdo P, Bellini G, Thomas MC, Fallo F, Veglio F, Johnston CI, Fabris B. High-salt diet increases glomerular ACE/ACE2 ratio leading to oxidative stress and kidney damage. Nephrol Dial Transplant 2012;27(5):1793-800.
  26. Bernardi S, Zauli G, Tikellis C, Candido R, Fabris B, Secchiero P, Cooper ME, Thomas MC. TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation. Clin Sci 2012;123(9):547-55.
  27. Bernardo BC, Charchar FJ, Lin RC, McMullen JR. A microRNA guide for clinicians and basic scientists: background and experimental techniques. Heart Lung Circ 2012;21(3):131-42. Review.
  28. Bernardo BC, Gao XM, Winbanks CE, Boey EJ, Tham YK, Kiriazis H, Gregorevic P, Obad S, Kauppinen S, Du XJ, Lin RC, McMullen JR. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci USA 2012;109(43):17615-20.
  29. Betihavas V, Davidson PM, Newton PJ, Frost SA, Macdonald PS, Stewart S. What are the factors in risk prediction models for rehospitalisation for adults with chronic heart failure? Aust Crit Care 2012;25(1):31-40.
  30. Bierhaus A, Fleming T, Stoyanov S, Leffler A, Babes A, Neacsu C, Sauer SK, Eberhardt M, Schnölzer M, Lasitschka F, Neuhuber WL, Kichko TI, Konrade I, Elvert R, Mier W, Pirags V, Lukic IK, Morcos M, Dehmer T, Rabbani N, Thornalley PJ, Edelstein D, Nau C, Forbes J, Humpert PM, Schwaninger M, Ziegler D, Stern DM, Cooper ME, Haberkorn U, Brownlee M, Reeh PW, Nawroth PP. Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat Med 2012;18(6):926-33.
  31. Birks S, Peeters A, Backholer K, O'Brien P, Brown W. A systematic review of the impact of weight loss on cancer incidence and mortality. Obes Rev 2012;13(10):868-91. Review.
  32. Bisping E, Ikeda S, Sedej M, Wakula P, McMullen JR, Tarnavski O, Sedej S, Izumo S, Pu WT, Pieske B. Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophy. J Biol Chem 2012;287(13):9827-34.
  33. Black MJ, Siebel AL, Gezmish O, Moritz KM, Wlodek ME. Normal lactational environment restores cardiomyocyte number after uteroplacental insufficiency: implications for the preterm neonate. Am J Physiol Regul Integr Comp Physiol 2012;302(9):R1101-10.
  34. Bobik A, Grassi G. Low-grade inflammation and arterial stiffness in the elderly. J Hypertens 2012;30(4):679-81. Editorial.
  35. Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, Simes RJ, Durrington P, Hitman GA, Welch KM, DeMicco DA, Zwinderman AH, Clearfield MB, Downs JR, Tonkin AM, Colhoun HM, Gotto AM Jr, Ridker PM, Kastelein JJ. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA 2012;307(12):1302-9. Review.
  36. Borg ML, Omran SF, Weir J, Meikle PJ, Watt MJ. Consumption of a high-fat diet, but not regular endurance exercise training, regulates hypothalamic lipid accumulation in mice. J Physiol 2012;590(Pt 17):4377-89.
  37. Boslem E, Meikle PJ, Biden TJ. Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunction. Islets 2012;4(3):177-87. Review.
  38. Bowring AL, Peeters A, Freak-Poli R, Lim MS, Gouillou M, Hellard M. Measuring the accuracy of self-reported height and weight in a community-based sample of young people. BMC Med Res Methodol 2012;12:175.
  39. Brown A, Scales U, Beever W, Rickards B, Rowley K, O'Dea K. Exploring the expression of depression and distress in Aboriginal men in central Australia: a qualitative study. BMC Psychiatry 2012;12:97.
  40. Brown RD, Hilliard LM, Head GA, Jones ES, Widdop RE, Denton KM. Sex differences in the pressor and tubuloglomerular feedback response to angiotensin II. Hypertension 2012;59(1):129-35.
  41. Bruce CR, Risis S, Babb JR, Yang C, Kowalski GM, Selathurai A, Lee-Young RS, Weir JM, Yoshioka K, Takuwa Y, Meikle PJ, Pitson SM, Febbraio MA. Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet-fed mice. Diabetes 2012;61(12):3148-55.
  42. Burch ML, Osman N, Getachew R, Al-Aryahi S, Poronnik P, Zheng W, Hill MA, Little PJ. G protein coupled receptor transactivation: extending the paradigm to include serine/threonine kinase receptors. Int J Biochem Cell Biol 2012;44(5):722-7.
  43. Cameron AJ, Magliano DJ, Dunstan DW, Zimmet PZ, Hesketh K, Peeters A, Shaw JE. A bi-directional relationship between obesity and health-related quality of life: evidence from the longitudinal AusDiab study. Int J Obes 2012;36(2):295-303.
  44. Cameron AJ, Magliano DJ, Shaw JE, Zimmet PZ, Carstensen B, Alberti KG, Tuomilehto J, Barr EL, Pauvaday VK, Kowlessur S, Söderberg S. The influence of hip circumference on the relationship between abdominal obesity and mortality. Int J Epidemiol 2012;41(2):484-94.
  45. Cameron JD, Dart AM. Misclassification of studies in 'Brachial artery tonometry and the Popeye phenomenon'. J Hypertens 2012;31(1):208. Letter.
  46. Cao Z, Cooper ME. Efficacy of renin-angiotensin system (RAS) blockers on cardiovascular and renal outcomes in patients with type 2 diabetes. Acta Diabetol 2012;49(4):243-54. Review.
  47. Carew RM, Wang B, Kantharidis P. The role of EMT in renal fibrosis. Cell Tissue Res 2012;347(1):103-16. Review.
  48. Carrington MJ, Grassi G. The threat of ethnicity for cardiovascular disease risk. J Hypertens 2012;30(2):269-70. Comment.
  49. Carrington MJ, Jennings GL, Clark RA, Stewart S. Assessing cardiovascular risk in regional areas: the Healthy Hearts Beyond City Limits program. BMC Health Serv Res 2012;12:296.
  50. Chan DC, Hoang A, Barrett PH, Wong AT, Nestel PJ, Sviridov D, Watts GF. Apolipoprotein B-100 and ApoA-II kinetics as determinants of cellular cholesterol efflux. J Clin Endocrinol Metab 2012;97(9):E1658-66.
  51. Chan DC, Ng TW, Watts GF. Apolipoprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis. Ann Med 2012;44(4):313-24. Review.
  52. Chan W, Ajani AE, Clark DJ, Stub D, Andrianopoulos N, Brennan AL, New G, Sebastian M, Johnston R, Walton A, Reid CM, Dart AM, Duffy SJ; Melbourne Interventional Group Investigators. Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention. Am J Cardiol 2012;109(4):471-7.
  53. Chan W, Duffy SJ, White DA, Gao XM, Du XJ, Ellims AH, Dart AM, Taylor AJ. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion. JACC Cardiovasc Imaging 2012;5(9):884-93.
  54. Chan W, Ellims AH, Duffy SJ, Kaye DM, Taylor AJ. Principles, current status and clinical implications of ischaemic heart disease assessment by cardiac magnetic resonance imaging. Intern Med J 2012;42(1):7-17. Review.
  55. Chan W, Stub D, Clark DJ, Ajani AE, Andrianopoulos N, Brennan AL, New G, Black A, Shaw JA, Reid CM, Dart AM, Duffy SJ; Melbourne Interventional Group Investigators. Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention. Am J Cardiol 2012;109(4):478-85.
  56. Chan W, Taylor AJ, Ellims AH, Lefkovits L, Wong C, Kingwell BA, Natoli A, Croft KD, Mori T, Kaye DM, Dart AM, Duffy SJ. Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction. Circ Cardiovasc Interv 2012;5(2):270-8.
  57. Chan YK, Stewart S, Calderone A, Scuffham P, Goldstein S, Carrington MJ; On behalf of the Young @ Heart Investigators. Exploring the potential to remain "Young @ Heart": initial findings of a multi-centre, randomised study of nurse-led, home-based intervention in a hybrid health care system. Int J Cardiol 2012;154(1):52-8.
  58. Chen D, Jancovski N, Bassi JK, Nguyen-Huu TP, Choong YT, Palma-Rigo K, Davern PJ, Gurley SB, Thomas WG, Head GA, Allen AM. Angiotensin type 1A receptors in C1 neurons of the rostral ventrolateral medulla modulate the pressor response to aversive stress. J Neurosci 2012;32(6):2051-61.
  59. Clark RA, Coffee N, Turner D, Eckert KA, van Gaans D, Wilkinson D, Stewart S, Tonkin AM; Cardiac Accessibility and Remoteness Index for Australia (Cardiac ARIA) Project Group. Application of geographic modeling techniques to quantify spatial access to health services before and after an acute cardiac event: the Cardiac Accessibility and Remoteness Index for Australia (ARIA) project. Circulation 2012;125(16):2006-14.
  60. Clifton P, Keough J. Nutrition and metabolism. Curr Opin Lipidol 2012;23(3):256-7. Comment.
  61. Clifton PM. Bariatric surgery: effects on the metabolic complications of obesity. Curr Atheroscler Rep 2012;14(2):95-100. Review.
  62. Coffee N, Turner D, Clark RA, Eckert K, Coombe D, Hugo G, Van Gaans D, Wilkinson D, Stewart S, Tonkin AA. Measuring national accessibility to cardiac services using geographic information systems. Appl Geog 2012;34(3):445-55.
  63. Coles LT, Clifton PM. Effect of beetroot juice on lowering blood pressure in free-living, disease-free adults: a randomized, placebo-controlled trial. Nutr J 2012;11:106.
  64. Comino EJ, Harris MF, Shaw JE, Jayasinghe UW. Detection of type 2 diabetes: what role for associated risk and protective factors and socioeconomic status? Aust Health Rev 2012;36(3):349-55.
  65. Cooley N, Cowley MJ, Lin RC, Marasco S, Wong C, Kaye DM, Dart AM, Woodcock EA. Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease. Physiol Genomics 2012;44(3):211-9.
  66. Cooper ME. Diabetes: treating diabetic nephropathy - still an unresolved issue. Nat Rev Endocrinol 2012;8(9):515-6. Review.
  67. Corcoran SJ, Lambert EA. Vasovagal syncope - the electricity, the pump or the input pressure? J Physiol 2012;590(pt 8):1775-6. Editorial.
  68. Cui HL, Grant A, Mukhamedova N, Pushkarsky T, Jennelle L, Dubrovsky L, Gaus K, Fitzgerald ML, Sviridov D, Bukrinsky M. HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux. J Lipid Res 2012;53(4):696-708.
  69. Cummings N, Shields KA, Curran JE, Bozaoglu K, Trevaskis J, Gluschenko K, Cai G, Comuzzie AG, Dyer TD, Walder KR, Zimmet P, Collier GR, Blangero J, Jowett JB. Genetic variation in SH3-domain GRB2-like (endophilin)-interacting protein 1 has a major impact on fat mass. Int J Obes 2012;36(2):201-6.
  70. Daly RM, Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Sikaris KA, Zimmet PZ, Ebeling PR, Shaw JE. Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol 2012;77(1):26-35.
  71. Damasiewicz MJ, Magliano DJ, Daly RM, Gagnon C, Lu ZX, Ebeling PR, Chadban SJ, Atkins RC, Kerr PG, Shaw JE, Polkinghorne KR. 25-hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. BMC Nephrol 2012;13:55.
  72. De Silva DA, Woon FP, Manzano JJ, Liu EY, Chang HM, Chen C, Wang JJ, Mitchell P, Kingwell BA, Cameron JD, Lindley RI, Wong TY, Wong MC. The relationship between aortic stiffness and changes in retinal microvessels among Asian ischemic stroke patients. J Hum Hypertens 2012;26(12):716-22.
  73. Demars J, Gicquel C. Epigenetic and genetic disturbance of the imprinted 11p15 region in Beckwith-Wiedemann and Silver-Russell syndromes. Clin Genet 2012;81(4):350-61. Review.
  74. d'Emden MC, Shaw JE, Colman PG, Colagiuri S, Twigg SM, Jones GR, Goodall I, Schneider HG, Cheung NW; Australian Diabetes Society; Royal College of Pathologists of Australasia; Australasian Association of Clinical Biochemists. The role of HbA1c in the diagnosis of diabetes mellitus in Australia. Med J Aust 2012;197(4):220-1. Guidelines.
  75. Despas F, Lambert E, Vaccaro A, Labrunee M, Franchitto N, Lebrin M, Galinier M, Senard JM, Lambert G, Esler M, Pathak A. Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure. J Hypertens 2012;30(4):753-60.
  76. Diehl P, Fricke A, Sander L, Stamm J, Bassler N, Htun N, Ziemann M,Helbing T, El-Osta A, Jowett J. Peter K. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res 2012;93(4):633-44. Review.
  77. Ding D, Sugiyama T, Owen N. Habitual active transport, TV viewing and weight gain: a four year follow-up study. Prev Med 2012;54(3-4):201-4.
  78. Ding D, Sugiyama T, Winkler E, Cerin E, Wijndaele K, Owen N. Correlates of change in adults' television viewing time: a four-year follow-up study. Med Sci Sports Exerc 2012;44(7):1287-92.
  79. Dinh TN, Kyaw TS, Kanellakis P, To K, Tipping P, Toh BH, Bobik A, Agrotis A. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis. Circulation 2012;126(10):1256-66.
  80. Dixon J. Obesity: health economics of bariatric surgery-benefit versus cost. Nat Rev Endocrinol 2012;8(11):632-3. Editorial.
  81. Dixon JB, Dixon BJ, Cobourn CS. Insights into proximal pouch dilatation following adjustable gastric banding-a form of inattentional blindness? Obes Surg 2012;22(7):999-1000. Editorial.
  82. Dixon JB, le Roux CW, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. Lancet 2012;379(9833):2300-11. Review.
  83. Dixon JB, Murphy DK, Segel JE, Finkelstein EA. Impact of laparoscopic adjustable gastric banding on type 2 diabetes. Obes Rev 2012;13(1):57-67. Review.
  84. Dixon JB, Schachter LM, O'Brien PE, Jones K, Grima M, Lambert G, Brown W, Bailey M, Naughton MT. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA 2012;308(11):1142-9.
  85. Dixon JB, Straznicky NE, Lambert EA, Schlaich MP, Lambert GW. Laparoscopic adjustable gastric banding and other devices for the management of obesity. Circulation 2012;126(6):774-85. Review.
  86. Doust J, Sanders S, Shaw J, Glasziou P. Prioritising CVD prevention therapy - absolute risk versus individual risk factors. Aust Fam Physician 2012;41(10):805-9.
  87. Drew BG, Rye KA, Duffy SJ, Barter P, Kingwell BA. The emerging role of HDL in glucose metabolism. Nat Rev Endocrinol 2012;8(4):237-45. Review.
  88. Driscoll A, Harvey C, Green A, Weatherby RP, Liew D, Prentice D, Lord J, Lee G, Crellin D, Dobroff N, Heland M. National nursing registration in Australia: a way forward for nurse practitioner endorsement. J Am Acad Nurse Pract 2012;24(3):143-8. Review.
  89. Dubrovsky L, Van Duyne R, Senina S, Guendel I, Pushkarsky T, Sviridov D, Kashanchi F, Bukrinsky M. Liver X receptor agonist inhibits HIV-1 replication and prevents HIV-induced reduction of plasma HDL in humanized mouse model of HIV infection. Biochem Biophys Res Commun 2012;419(1):95-8.
  90. Dunstan DW, Howard B, Healy GN, Owen N. Too much sitting - a health hazard. Diabetes Res Clin Pract 2012;97(3):368-76. Review.
  91. Dunstan DW, Kingwell BA, Larsen R, Healy GN, Cerin E, Hamilton MT, Shaw JE, Bertovic DA, Zimmet PZ, Salmon J, Owen N. Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diabetes Care 2012;35(5):976-83.
  92. Dunstan DW, Owen N. New exercise prescription: don't just sit there: stand up and move more, more often. Arch Intern Med 2012;172(6):500-1. Comment.
  93. Eades SJ, Sanson-Fisher RW, Wenitong M, Panaretto K, D'Este C, Gilligan C, Stewart J. An intensive smoking intervention for pregnant Aboriginal and Torres Strait Islander women: a randomised controlled trial. Med J Aust 2012;197(1):42-6.
  94. Edwards AM, Maguire GP, Graham D, Boland V, Richardson G. Four weeks of inspiratory muscle training improves self-paced walking performance in overweight and obese adults: a randomised controlled trial. J Obes 2012;2012:918202.
  95. Eisenhardt SU, Starke J, Thiele JR, Murphy A, Björn Stark G, Bassler N, Sviridov D, Winkler K, Peter K. Pentameric CRP attenuates inflammatory effects of mmLDL by inhibiting mmLDL-monocyte interactions. Atherosclerosis 2012;224(2):384-93.
  96. Ellims AH, Iles LM, Ling LH, Hare JL, Kaye DM, Taylor AJ. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Reson 2012;14:76.
  97. El-Osta A. Glycemic memory. Curr Opin Lipidol 2012;23(1):24-9. Review.
  98. El-Osta A. Redox mediating epigenetic changes confer metabolic memories. Circ Res 2012;111(3):262-4. Editorial.
  99. Elsik M, Teh A, Ling LH, Virdee M, Parameshwar J, Fynn SP, Kistler PM. Supraventricular arrhythmias late after orthotopic cardiac transplantation: electrocardiographic and electrophysiological characterization and radiofrequency ablation. Europace 2012;14(10):1498-505.
  100. Emerging Risk Factors Collaboration. Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. Int J Epidemiol 2012;41(5):1419-33.
  101. Eppel GA, Head GA, Denton KM, Evans RG. Effects of tempol and candesartan on neural control of the kidney. Auton Neurosci-Basic Clin 2012;168(1-2):48-57.
  102. Esler MD, Krum H, Schlaich M, Schmieder RE, Böhm M, Sobotka PA; Symplicity HTN-2 Investigators. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation 2012;126(25):2976-82.
  103. Fagerholm E, Ahlqvist E, Forsblom C, Sandholm N, Syreeni A, Parkkonen M, McKnight AJ, Tarnow L, Maxwell AP, Parving HH, Groop L, Groop PH; on behalf of the FinnDiane Study Group. SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes. Diabetologia 2012;55(9):2386-93.
  104. Fan FL, Dart AM. Anti-inflammatory treatment in patients after percutaneous coronary intervention: another potential use for berberine? Clin Exp Pharmacol Physiol 2012;39(5):404-5. Editorial.
  105. Fang L, Moore XL, Chan W, White DA, Chin-Dusting J, Dart AM. Decreased fibrocyte number is associated with atherosclerotic plaque instability in man. Cardiovasc Res 2012;95(1):124-33.
  106. Feil SC, Hamilton S, Krippner GY, Lin B, Luttick A, McConnell DB, Nearn R, Parker MW, Ryan J, Stanislawski PC, Tucker SP, Watson KG, Morton CJ. An orally available 3-ethoxybenzisoxazole capsid binder with clinical activity against human rhinovirus. ACS Med Chem Lett 2012;3(4):303-7. Letter.
  107. Forbes JM, Cooper ME. Glycation in diabetic nephropathy. Amino Acids 2012;42(4):1185-92. Review.
  108. Fountaine T, Shaw JE, Zimmet PZ. Designing payments for GPs to improve the quality of diabetes care. Med J Aust 2012;196(9):568. Comment.
  109. Freak-Poli R, Peeters A. The contribution of workplace characteristics to the risk of type 2 diabetes. Curr Med Literature: Diabetes 2012;29(3):65-76. Review.
  110. Fu Y, Moore XL, Lee MK, Fernández-Rojo MA, Parat MO, Parton RG, Meikle PJ, Sviridov D, Chin-Dusting JP. Caveolin-1 plays a critical role in the differentiation of monocytes into macrophages. Arterioscler Thromb Vasc Biol 2012;32(9):e117-25.
  111. Fuller M, Duplock S, Turner C, Davey P, Brooks DA, Hopwood JJ, Meikle PJ. Mass spectrometric quantification of glycogen to assess primary substrate accumulation in the Pompe mouse. Anal Biochem 2012;421(2):759-63.
  112. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, Sikaris K, Ebeling PR, Daly RM. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab 2012;97(6):1953-61.
  113. Gao XM, White DA, Dart AM, Du XJ. Post-infarct cardiac rupture: recent insights on pathogenesis and therapeutic interventions. Pharmacol Ther 2012;134(2):156-79. Review.
  114. Geake JB, Maguire G. Acute spontaneously resolving pulmonary vasculitis: a case report. Case Rep Immunol 2012;2012:706838.
  115. Gehrig SM, van der Poel C, Sayer TA, Schertzer JD, Henstridge DC, Church JE, Lamon S, Russell AP, Davies KE, Febbraio MA, Lynch GS. Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature 2012;484(7394):394-8.
  116. Geisler BP, Egan BM, Cohen JT, Garner AM, Akehurst RL, Esler MD, Pietzsch JB. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension. J Am Coll Cardiol 2012;60(14):1271-7.
  117. Graham S, Guy RJ, Donovan B, McManus H, Su JY, El-Hayek C, Kwan KS, Dyda A, Wand HC, Ward JS. Epidemiology of chlamydia and gonorrhoea among Indigenous and non-Indigenous Australians, 2000-2009. Med J Aust 2012;197(11):642-6.
  118. Granat M, Bussmann H, Lovell N, Owen N, Salmon J, Stansfield B. 2nd International conference on ambulatory monitoring of physical activity and movement (Glasgow Caledonian University, UK, 24-27 May 2011). Physiol Meas 2012;33(11):2p. Editorial.
  119. Grubb DR, Luo J, Yu YL, Woodcock EA. Scaffolding protein Homer 1c mediates hypertrophic responses downstream of Gq in cardiomyocytes. FASEB J 2012;26(2):596-603.
  120. Gu HP, Lin S, Xu M, Yu HY, Du XJ, Zhang YY, Yuan G, Gao W. Up-regulating relaxin expression by G-quadruplex interactive ligand to achieve antifibrotic action. Endocrinology 2012;153(8):3692-700.
  121. Habersberger J, Brott TG, Roubin GS. Carotid artery stenting: a clinical update. Curr Opin Cardiol 2012;27(6):565-71. Review.
  122. Habersberger J, Strang F, Scheichl A, Htun N, Bassler N, Merivirta RM, Diehl P, Krippner G, Meikle P, Eisenhardt SU, Meredith I, Peter K. Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction. Cardiovasc Res 2012;96(1):64-72.
  123. Haby MM, Markwick A, Peeters A, Shaw J, Vos T. Future predictions of body mass index and overweight prevalence in Australia, 2005-2025. Health Promot Int 2012;27(2):250-60.
  124. Hagiwara S, Kantharidis P, Cooper ME. What are new avenues for renal protection, in addition to RAAS inhibition? Curr Hypertens Rep 2012;14(2):100-10. Review.
  125. Hansen AL, Wijndaele K, Owen N, Magliano DJ, Thorp AA, Shaw JE, Dunstan DW. Adverse associations of increases in television viewing time with 5-year changes in glucose homoeostasis markers: the AusDiab study. Diabetic Med 2012;29(7):918-25.
  126. Harcourt BE, Forbes JM, Matthews VB. Obesity-induced renal impairment is exacerbated in interleukin-6-knockout mice. Nephrology 2012;17(3):257-62.
  127. Harding JL, Soderberg S, Shaw JE, Zimmet PZ, Pauvaday V, Kowlessur S, Tuomilehto J, Alberti KG, J Magliano D. All-cause cancer mortality over 15 years in multi-ethnic Mauritius: the impact of diabetes and intermediate forms of glucose tolerance. Int J Cancer 2012;131(10):2385-93.
  128. Hardy CL, Lemasurier JS, Belz GT, Scalzo-Inguanti K, Yao J, Xiang SD, Kanellakis P, Bobik A, Strickland DH, Rolland JM, O'Hehir RE, Plebanski M. Inert 50-nm polystyrene nanoparticles that modify pulmonary dendritic cell function and inhibit allergic airway inflammation. J Immunol 2012;188(3):1431-41.
  129. Hare MJ, Shaw JE, Zimmet PZ. Current controversies in the use of haemoglobin A1c. J Intern Med 2012;271(3):227-36. Review.
  130. Hayes K, Leet AS, Bradley SJ, Holland AE. Effects of exercise training on exercise capacity and quality of life in patients with a left ventricular assist device: a preliminary randomized controlled trial. J Heart Lung Transplant 2012;31(7):729-34.
  131. Head GA, McGrath BP, Mihailidou AS, Nelson MR, Schlaich MP, Stowasser M, Mangoni AA, Cowley D, Brown MA, Ruta LA, Wilson A. Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement. J Hypertens 2012;30(2):253-66. Statement.
  132. Head GA, McGrath BP, Nelson MR, Stowasser M. Importance of ambulatory blood pressure in hypertension management. Med J Aust 2012;197(3):143-4. Comment.
  133. Head GA, Shaw J. An update on blood pressure and type 2 diabetes. Diabetes Manag J 2012;40:16-9. Review.
  134. Heath GW, Parra DC, Sarmiento OL, Andersen LB, Owen N, Goenka S, Montes F, Brownson RC; Lancet Physical Activity Series Working Group. Evidence-based intervention in physical activity: lessons from around the world. Lancet 2012;280(9838):272-81. Review.
  135. Henry SL, Barzel B, Wood-Bradley RJ, Burke SL, Head GA, Armitage JA. Developmental origins of obesity-related hypertension. Clin Exp Pharmacol Physiol 2012;39(9):799-806. Review.
  136. Henry SL, Bensley JG, Wood-Bradley RJ, Cullen-McEwen LA, Bertram JF, Armitage JA. White adipocytes: more than just fat depots. Int J Biochem Cell Biol 2012;44(3):435-40. Review.
  137. Henstridge DC, Bruce CR, Pang CP, Lancaster GI, Allen TL, Estevez E, Gardner T, Weir JM, Meikle PJ, Lam KS, Xu A, Fujii N, Goodyear LJ, Febbraio MA. Skeletal muscle-specific overproduction of constitutively activated c-Jun N-terminal kinase (JNK) induces insulin resistance in mice. Diabetologia 2012;55(10):2769-78.
  138. Hering D, Esler MD, Schlaich MP. Effects of renal denervation on insulin resistance. Expert Rev Cardiovasc Ther 2012;10(11):1381-6. Review.
  139. Hering D, Mahfoud F, Walton AS, Krum H, Lambert GW, Lambert EA, Sobotka PA, Böhm M, Cremers B, Esler MD, Schlaich MP. Renal denervation in moderate to severe CKD. J Am Soc Nephrol 2012;23(7):1250-7.
  140. Hering D, Walton A, Krum H, Lambert GW, Esler MD, Schlaich MP. Renal nerve ablation reduces blood pressure in a patient with renovascular hypertension resistant to drug and revascularisation therapies. Int J Cardiol 2012;159(2):e35-6. Letter.
  141. Herman WH, Zimmet P. Type 2 diabetes: an epidemic requiring global attention and urgent action. Diabetes Care 2012;35(5):943-4. Comment.
  142. Hoang A, Drew BG, Low H, Remaley AT, Nestel P, Kingwell BA, Sviridov D. Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein. Eur Heart J 2012;33(5):657-65.
  143. Hordern MD, Dunstan DW, Prins JB, Baker MK, Singh MA, Coombes JS. Exercise prescription for patients with type 2 diabetes and pre-diabetes: a position statement from Exercise and Sport Science Australia. J Sci Med Sport 2012;15(1):25-31. Statement.
  144. Hunter RJ, McCready J, Diab I, Page SP, Finlay M, Richmond L, French A, Earley MJ, Sporton S, Jones M, Joseph JP, Bashir Y, Betts TR, Thomas G, Staniforth A, Lee G, Kistler P, Rajappan K, Chow A, Schilling RJ. Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death. Heart 2012;98(1):48-53.
  145. Huynh K, Kiriazis H, Du XJ, Love JE, Jandeleit-Dahm KA, Forbes JM, McMullen JR, Ritchie RH. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes. Diabetologia 2012;55(5):1544-53.
  146. Inoue S, Sugiyama T, Takamiya T, Oka K, Owen N, Shimomitsu T. Television viewing time is associated with overweight/obesity among older adults, independent of meeting physical activity and health guidelines. J Epidemiol 2012;22(1):50-6.
  147. Irvine JC, Ganthavee V, Love JE, Alexander AE, Horowitz JD, Stasch JP, Kemp-Harper BK, Ritchie RH. The soluble guanylyl cyclase activator BAY 58-2667 selectively limits cardiomyocyte hypertrophy. PLoS One 2012;7(11):e44481.
  148. Iyngkaran P, Thomas M, Majoni W, Anavekar NS, Ronco C. Comorbid heart failure and renal impairment: epidemiology and management. Cardiorenal Med 2012;2(4):281-97. Review.
  149. Jamieson LM, Paradies YC, Eades S, Chong A, Maple-Brown L, Morris P, Bailie R, Cass A, Roberts-Thomson K, Brown A. Ten principles relevant to health research among Indigenous Australian populations. Med J Aust 2012;197(1):16-8. Comment.
  150. Jandeleit-Dahm K, Gray SP. Insulin and cardiovascular disease: biomarker or association? Diabetologia 2012;55(12):3145-51. Review.
  151. Jandeleit-Dahm KA, Watson AM. The endothelin system and endothelin receptor antagonists. Curr Opin Nephrol Hypertens 2012;21(1):66-71. Review.
  152. Jesudason DR, Clifton P. Interpreting different measures of glomerular filtration rate in obesity and weight loss: pitfalls for the clinician. Int J Obes 2012;36(11):1421-7. Review.
  153. Jones KM, Dixon ME, Dixon JB. General practice research: does gender affect the decision to participate? Aust Fam Physician 2012;41(6):419-23.
  154. Jordan J, Yumuk V, Schlaich M, Nilsson PM, Zahorska-Markiewicz B, Grassi G, Schmieder RE, Engeli S, Finer N. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: Obesity and difficult to treat arterial hypertension. J Hypertens 2012;30(6):1047-55. Statement.
  155. Jowett JB, Okada Y, Leedman PJ, Curran JE, Johnson MP, Moses EK, Goring HH, Mochizuki S, Blangero J, Stone L, Allen H, Mitchell C, Matthews VB. ADAM28 is elevated in humans with the metabolic syndrome and is a novel sheddase of human tumour necrosis factor-α. Immunol Cell Biol 2012;90(10):966-73.
  156. Ju YK, Woodcock EA, Allen DG, Cannell MB. Inositol 1,4,5-trisphosphate receptors and pacemaker rhythms. J Mol Cell Cardiol 2012;53(3):375-81. Review.
  157. Kampe J, Stefanidis A, Lockie SH, Brown WA, Dixon JB, Odoi A, Spencer SJ, Raven J, Oldfield BJ. Neural and humoral changes associated with the adjustable gastric band: insights from a rodent model. Int J Obes 2012;36(11):1403-11.
  158. Kandzari DE, Bhatt DL, Sobotka PA, O'Neill WW, Esler M, Flack JM, Katzen BT, Leon MB, Massaro JM, Negoita M, Oparil S, Rocha-Singh K, Straley C, Townsend RR, Bakris G. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 trial. Clin Cardiol 2012;35(9):528-35. Review.
  159. Kanellakis P, Ditiatkovski M, Kostolias G, Bobik A. A pro-fibrotic role for interleukin-4 in cardiac pressure overload. Cardiovasc Res 2012;95(1):77-85.
  160. Kapustin A, Stepanova V, Aniol N, Cines DB, Poliakov A, Yarovoi S, Lebedeva T, Wait R, Ryzhakov G, Parfyonova Y, Gursky Y, Yanagisawa H, Minashkin M, Beabealashvilli R, Vorotnikov A, Bobik A, Tkachuk V. Fibulin-5 binds urokinase type plasminogen activator and mediates urokinase-stimulated β1-integrin-dependent cell migration. Biochem J 2012;443(2):491-503.
  161. Karagiannis TC, Li X, Tang MM, Orlowski C, El-Osta A, Tang ML, Royce SG. Molecular model of naphthalene-induced DNA damage in the murine lung. Hum Exp Toxicol 2012;31(1):42-50.
  162. Karagiannis TC, Maulik N. Factors influencing epigenetic mechanisms and related diseases. Antioxid Redox Signal 2012;17(2):192-4. Editorial.
  163. Karagiannis TC, Ververis K. Potential of chromatin modifying compounds for the treatment of Alzheimer's disease. Pathobiol Aging Age Relat Dis 2012;2:14980. Review.
  164. Kaspi A, Ziemann M, Rafehi H, Lazarus R, El-Osta A. A pipeline for the identification and characterization of chromatin modifications derived from ChIP-Seq datasets. Biochimie 2012;94(11):2353-9. Review.
  165. Katz ME, Margulis F, Schiavelli R, Arias P, Head GA, Golombek DA. Disruption of transitional stages in 24-h blood pressure recording in renal transplant recipients. Front Neurol 2012;3:35.
  166. Keating CL, Moodie ML, Bulfone L, Swinburn BA, Stevenson CE, Peeters A. Healthcare utilization and costs in severely obese subjects before bariatric surgery. Obesity 2012;20(12):2412-9.
  167. Keating ST, El-Osta A. Chromatin modifications associated with diabetes. J Cardiovasc Transl Res 2012;5(4):399-412. Review.
  168. Kent JW Jr, Göring HH, Charlesworth JC, Drigalenko E, Diego VP, Curran JE, Johnson MP, Dyer TD, Cole SA, Jowett JB, Mahaney MC, Comuzzie AG, Almasy L, Moses EK, Blangero J, Williams-Blangero S. Genotype×age interaction in human transcriptional ageing. Mech Ageing Dev 2012;133(9-10):581-90.
  169. Keogh JB, Cleanthous X, Wycherley TP, Brinkworth GD, Noakes M, Clifton PM. Increased thiamine intake may be required to maintain thiamine status during weight loss in patients with type 2 diabetes. Diabetes Res Clin Pract 2012;98(3):e40-2.
  170. Keogh JB, Clifton PM. Meal replacements for weight loss in type 2 diabetes in a community setting. J Nutr Metab 2012;2012:918571.
  171. Khong S, Andrews K, Huynh N, Venardos K, Aprico A, Michell D, Zarei M, Moe K, Dusting G, Kaye D, Chin-Dusting J. Arginase II inhibition prevents nitrate tolerance. Br J Pharmacol 2012;166(7):2015-23.
  172. Kiriazis H, Jennings NL, Davern P, Lambert G, Su Y, Pang T, Du X, La Greca L, Head GA, Hannan AJ, Du XJ. Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease. J Physiol 2012;590(Pt 2):5845-60.
  173. Koulis C, de Haan JB, Allen TJ. Novel pathways and therapies in experimental diabetic atherosclerosis. Expert Rev Cardiovasc Ther 2012;10(3):323-35. Review.
  174. Krajewski S, Kurz J, Geisler T, Peter K, Wendel HP, Straub A. Combined blockade of ADP receptors and PI3-kinase p110β fully prevents platelet and leukocyte activation during hypothermic extracorporeal circulation. PLoS One 2012;7(7):e38455.
  175. Krajewski S, Kurz J, Neumann B, Greiner TO, Stolz A, Balkau B, Peter K, Unertl K, Wendel HP, Straub A. Short-acting P2Y12 blockade to reduce platelet dysfunction and coagulopathy during experimental extracorporeal circulation and hypothermia. Br J Anaesth 2012;108(6):912-21.
  176. Kumar S, Ling LH, Halloran K, Morton JB, Spence SJ, Joseph S, Kistler PM, Sparks PB, Kalman JM. Esophageal hematoma after atrial fibrillation ablation: incidence, clinical features, and sequelae of esophageal injury of a different sort. Circ Arrhythm Electrophysiol 2012;5(4):701-5.
  177. Kumar S, Morton JB, Halloran K, Spence SJ, Lee G, Wong MC, Kistler PM, Kalman JM. Effect of respiration on catheter-tissue contact force during ablation of atrial arrhythmias. Heart Rhythm 2012;9(7):1041-7.e1.
  178. Kumar S, Morton JB, Lee J, Halloran K, Spence SJ, Gorelik A, Hepworth G, Kistler PM, Kalman JM. Prospective characterization of catheter-tissue contact force at different anatomic sites during antral pulmonary vein isolation. Circ Arrhythm Electrophysiol 2012;5(6):1124-9.
  179. Kumar S, Teh AW, Medi C, Kistler PM, Morton JB, Kalman JM. Atrial remodeling in varying clinical substrates within beating human hearts: relevance to atrial fibrillation. Prog Biophys Mol Biol 2012;110(2-3):278-94. Review.
  180. Kume S, Thomas MC, Koya D. Nutrient sensing, autophagy, and diabetic nephropathy. Diabetes 2012;61(1):23-9. Review.
  181. Kyaw T, Tay C, Hosseini H, Kanellakis P, Gadowski T, Mackay F, Tipping P, Bobik A, Toh BH. Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE-/- mice attenuates atherosclerosis by potently ameliorating arterial inflammation. PLoS One 2012;7(1):e29371.
  182. Kyaw T, Tipping P, Bobik A, Toh BH. Protective role of natural IgM-producing B1a cells in atherosclerosis. Trends Cardiovasc Med 2012;22(2):48-53. Review.
  183. La Gerche A, Burns AT, Mooney DJ, Inder WJ, Taylor AJ, Bogaert J, Macisaac AI, Heidbüchel H, Prior DL. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J 2012;33(8):998-1006.
  184. La Gerche A, Burns AT, Taylor AJ, Macisaac AI, Heidbüchel H, Prior DL. Maximal oxygen consumption is best predicted by measures of cardiac size rather than function in healthy adults. Eur J Appl Physiol 2012;112(6):2139-47.
  185. Laker RC, Wlodek ME, Wadley GD, Gallo LA, Meikle PJ, McConell GK. Exercise early in life in rats born small does not normalize reductions in skeletal muscle PGC-1α in adulthood. Am J Physiol Endocrinol Metab 2012;302(10):E1221-30.
  186. Lam NT, Currie PD, Lieschke GJ, Rosenthal NA, Kaye DM. Nerve growth factor stimulates cardiac regeneration via cardiomyocyte proliferation in experimental heart failure. PLoS One 2012;7(12):e53210.
  187. Lambert E, Hering D, Schlaich M, Lambert G. Advances in sympathetic nerve recording in humans. Front Physiol 2012;3:11. Review.
  188. Lambert GW, Hering D, Esler MD, Marusic P, Lambert EA, Tanamas SK, Shaw J, Krum H, Dixon JB, Barton DA, Schlaich MP. Health-related quality of life after renal denervation in patients with treatment-resistant hypertension. Hypertension 2012;60:1479-84.
  189. Lancaster GI, Kowalski GM, Estevez E, Kraakman MJ, Grigoriadis G, Febbraio MA, Gerondakis S, Banerjee A. Tumor progression locus 2 (Tpl2) deficiency does not protect against obesity-induced metabolic disease. PLoS One 2012;7(6):e39100.
  190. Lancaster GI, Skiba B, Yang C, Nicholls HT, Langley KG, Chan MS, Bruce CR, Rewcastle GW, Shepherd PR, Karin M, Febbraio MA. IκB kinase β (IKKβ) does not mediate feedback inhibition of the insulin-signaling cascade. Biochem J 2012;442(3):723-32.
  191. Larsson P, Ulfhammer E, Magnusson M, Bergh N, Lunke S, El-Osta A, Medcalf RL, Svensson PA, Karlsson L, Jern S. Role of histone acetylation in the stimulatory effect of valproic Acid on vascular endothelial tissue-type plasminogen activator expression. PLoS One 2012;7(2):e31573.
  192. Laurent S, Schlaich M, Esler M. New drugs, procedures, and devices for hypertension. Lancet 2012;380(9841):591-600. Review.
  193. Lawler S, McDermott L, O'Riordan D, Spathonis K, Eakin E, Leslie E, Gallois C, Berndt N, Owen N. Relationships of sun-protection habit strength with sunscreen use during outdoor sport and physical activity. Int J Environ Res Public Health 2012;9(3):916-23.
  194. Lazarus R, Kaspi A, Ziemann M; The Galaxy Team. Creating reusable tools from scripts: the Galaxy Tool Factory. Bioinformatics 2012;28(23):3139-40.
  195. Lee G, Spence S, Teh A, Goldblatt J, Larobina M, Atkinson V, Brown R, Morton JB, Sanders P, Kistler PM, Kalman JM. High-density epicardial mapping of the pulmonary vein-left atrial junction in humans: insights into mechanisms of pulmonary vein arrhythmogenesis. Heart Rhythm 2012;9(2):258-64.
  196. Lee NM, Carter A, Owen N, Hall WD. The neurobiology of overeating. Treating overweight individuals should make use of neuroscience research, but not at the expense of population approaches to diet and lifestyle. EMBO Rep 2012;13(9):785-90. Review.
  197. Lee SP, Dart AM, Walker KZ, O'Dea K, Chin-Dusting JP, Skilton MR. Effect of altering dietary n-6:n-3 PUFA ratio on cardiovascular risk measures in patients treated with statins: a pilot study. Br J Nutr 2012;108(7):1280-5.
  198. Leung MK, Hagemeyer CE, Johnston AP, Gonzales C, Kamphuis MM, Ardipradja K, Such GK, Peter K, Caruso F. Bio-click chemistry: enzymatic functionalization of PEGylated capsules for targeting applications. Angew Chem Int Edit 2012;51(29):7132-6.
  199. Licciardi PV, Kwa FAA, Ververis K, Di Costanzo N, Balcerczyk A, Tang ML, El-Osta A, Karagiannis TC. Influence of natural and synthetic histone deacetylase inhibitors on chromatin. Antioxid Redox Signal 2012;17(2):340-54.
  200. Lim K, Burke SL, Armitage JA, Head GA. Comparison of blood pressure and sympathetic activity of rabbits in their home cage and the laboratory environment. Exp Physiol 2012;97(12):1263-71.
  201. Lin EQ, Irvine JC, Cao AH, Alexander AE, Love JE, Patel R, McMullen JR, Kaye DM, Kemp-Harper BK, Ritchie RH. Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation. PLoS One 2012;7(4):e34892.
  202. Ling LH, Khammy O, Byrne M, Amirahmadi F, Foster A, Li G, Zhang L, Remedios CD, Chen C, Kaye DM. Irregular rhythm adversely influences calcium handling in ventricular myocardium: implications for the interaction between heart failure and atrial fibrillation. Circ Heart Fail 2012;5(6):786-93.
  203. Ling LH, Kistler PM, Ellims AH, Iles LM, Lee G, Hughes GL, Kalman JM, Kaye DM, Taylor AJ. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. J Am Coll Cardiol 2012;60(23):2402-8.
  204. Liu B, Guthridge S, Li SQ, Markey P, Krause V, McIntyre P, Sullivan E, Ward J, Wood N, Kaldor JM. The end of the Australia antigen? An ecological study of the impact of universal newborn hepatitis B vaccination two decades on. Vaccine 2012;30(50):7309-14.
  205. Liu J, Wang B, Hartono SB, Liu T, Kantharidis P, Middelberg AP, Lu GQ, He L, Qiao SZ. Magnetic silica spheres with large nanopores for nucleic acid adsorption and cellular uptake. Biomaterials 2012;33(3):970-8.
  206. Liu Y, Jennings NL, Dart AM, Du XJ. Standardizing a simpler, more sensitive and accurate tail bleeding assay in mice. World J Exp Med 2012;2(2):30-6.
  207. Low H, Hoang A, Forbes J, Thomas M, Lyons JG, Nestel P, Bach LA, Sviridov D. Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models. Diabetologia 2012;55(9):2513-21.
  208. Low H, Hoang A, Sviridov D. Cholesterol efflux assay. J Vis Exp 2012;(61):e3810. Video.
  209. Maeder MT, Kaye DM. Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction. Int J Cardiol 2012;155(2):249-56.
  210. Maeder MT, Thompson BR, Htun N, Kaye DM. Hemodynamic determinants of the abnormal cardiopulmonary exercise response in heart failure with preserved left ventricular ejection fraction. J Card Fail 2012;18(9):702-10.
  211. Magliano DJ, Davis WA, Shaw JE, Bruce DG, Davis TM. Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle Diabetes Study. Eur J Endocrinol 2012;167(4):589-99.
  212. Magliano DJ, Söderberg S, Zimmet PZ, Chen L, Joonas N, Kowlessur S, Larhubarbe J, Gaoneadry D, Pauvaday V, Tuomilehto J, Alberti KG, Shaw JE. Explaining the increase of diabetes prevalence and plasma glucose in Mauritius. Diabetes Care 2012;35(1):87-91.
  213. Maguire G. Bronchiectasis: a guide for primary care. Aust Fam Physician 2012;41(11):842-50. Review.
  214. Maguire GP, Carapetis JR, Walsh WF, Brown AD. The future of acute rheumatic fever and rheumatic heart disease in Australia. Med J Aust 2012;197(3):133-4. Editorial.
  215. Mahfoud F, Cremers B, Janker J, Link B, Vonend O, Ukena C, Linz D, Schmieder R, Rump LC, Kindermann I, Sobotka PA, Krum H, Scheller B, Schlaich M, Laufs U, Böhm M. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension 2012;60(2):419-24.
  216. Mäkinen VP, Tynkkynen T, Soininen P, Peltola T, Kangas AJ, Forsblom C, Thorn LM, Kaski K, Laatikainen R, Ala-Korpela M, Groop PH. Metabolic diversity of progressive kidney disease in 325 patients with type 1 diabetes (the FinnDiane Study). J Proteome Res 2012;11(3):1782-90.
  217. Malan L, Hamer M, Schlaich MP, Lambert GW, Harvey BH, Reimann M, Ziemssen T, Geus EJ, Huisman HW, Rooyen JM, Schutte R, Schutte AE, Fourie CM, Seedat YK, Malan NT. Facilitated defensive coping, silent ischaemia and ECG left-ventricular hypertrophy: the SABPA study. J Hypertens 2012;30(3):543-550.
  218. Malan NT, Hamer M, Lambert GW, Schutte AE, Huisman HW, Van Rooyen JM, Mels CM, Smith W, Fourie CM, Schutte R, Kruger R, Malan L. Sex hormones associated with subclinical kidney damage and atherosclerosis in South African men: the SABPA study. J Hypertens 2012;30(12):2387-94.
  219. Manns PJ, Dunstan DW, Owen N, Healy GN. Addressing the nonexercise part of the activity continuum: a more realistic and achievable approach to activity programming for adults with mobility disability? Phys Ther 2012;92(4):614-25. Review.
  220. Maple-Brown LJ, Cunningham J, Zinman B, Mamakeesick M, Harris SB, Connelly PW, Shaw J, O'Dea K, Hanley AJ. Cardiovascular disease risk profile and microvascular complications of diabetes: comparison of Indigenous cohorts with diabetes in Australia and Canada. Cardiovasc Diabetol 2012;11:30.
  221. Maple-Brown LJ, Hughes JT, Lawton PD, Jones GR, Ellis AG, Drabsch K, Brown AD, Cass A, Hoy WE, Macisaac RJ, O'Dea K, Jerums G. Accurate assessment of kidney function in indigenous Australians: the estimated GFR study. Am J Kidney Dis 2012;60(4):680-2. Letter.
  222. Marley JV, Atkinson D, Nelson C, Kitaura T, Gray D, Metcalf S, Murray R, Maguire GP. The protocol for the Be Our Ally Beat Smoking (BOABS) study, a randomised controlled trial of an intensive smoking cessation intervention in a remote Aboriginal Australian health care setting. BMC Public Health 2012;12:232. Protocol.
  223. Martinez-Gomez D, Eisenmann JC, Healy GN, Gomez-Martinez S, Diaz LE, Dunstan DW, Veiga OL, Marcos A; AFINOS Study Group. Sedentary behaviors and emerging cardiometabolic biomarkers in adolescents. J Pediatr 2012;160(1):104-110.
  224. Mason RR, Meex RC, Lee-Young R, Canny BJ, Watt MJ. Phosphorylation of adipose triglyceride lipase Ser404 is not related to 5'-AMPK activation during moderate-intensity exercise in humans. Am J Physiol Endocrinol Metab 2012;303(4):E534-41.
  225. Masuo K, Rakugi H, Ogihara T, Lambert GW. Different mechanisms in weight loss-induced blood pressure reduction between a calorie-restricted diet and exercise. Hypertens Res 2012;35(1):41-7.
  226. Matsumoto A, Mason SR, Flatscher-Bader T, Ward LC, Marsh SA, Wilce PA, Fassett RG, de Haan JB, Coombes JS. Effects of exercise and antioxidant supplementation on endothelial gene expression. Int J Cardiol 2012;158(1):59-65.
  227. McConell GK, Rattigan S, Lee-Young RS, Wadley GD, Merry TL. Skeletal muscle nitric oxide signaling and exercise: a focus on glucose metabolism. Am J Physiol Endocrinol Metab 2012;303(3):E301-7. Review.
  228. McGee TL, Grima MT, Hewson ID, Jones KM, Duke EB, Dixon JB. First Australian experiences with an oral volume restriction device to change eating behaviors and assist with weight loss. Obesity 2012;20(1):126-33.
  229. McGrady M, Krum H, Carrington MJ, Stewart S, Zeitz C, Lee GA, Marwick TH, Haluska BA, Brown A. Heart failure, ventricular dysfunction and risk factor prevalence in Australian Aboriginal peoples: the Heart of the Heart Study. Heart 2012;98(21):1562-7.
  230. McIver CM, Wycherley TP, Clifton PM. mTOR signaling and ubiquitin-proteosome gene expression in the preservation of fat free mass following high protein, calorie restricted weight loss. Nutr Metab 2012;9(1):83. Review.
  231. McLellan AJ, McKenzie SC, Taylor AJ. Cardiac magnetic resonance imaging predicts recovery of left ventricular function in acute onset cardiomyopathy. Heart Lung Circ 2012;21(1):30-5.
  232. McNamara BJ, Gubhaju L, Chamberlain C, Stanley F, Eades SJ. Early life influences on cardio-metabolic disease risk in aboriginal populations-what is the evidence? A systematic review of longitudinal and case-control studies. Int J Epidemiol 2012;41(6):1661-82.
  233. Medi C, Kalman JM, Ling LH, Teh AW, Lee G, Lee G, Spence SJ, Kaye DM, Kistler PM. Atrial electrical and structural remodeling associated with longstanding pulmonary hypertension and right ventricular hypertrophy in humans. J Cardiovasc Electrophysiol 2012;23(6):614-20.
  234. Medi C, Teh AW, Roberts-Thomson K, Morton JB, Kistler PM, Kalman JM. Right atrial remodeling is more advanced in patients with atrial flutter than with atrial fibrillation. J Cardiovasc Electrophysiol 2012;23(10):1067-72.
  235. Mellor KM, Wendt IR, Ritchie RH, Delbridge LM. Fructose diet treatment in mice induces fundamental disturbance of cardiomyocyte Ca2+ handling and myofilament responsiveness. Am J Physiol Heart Circ Physiol 2012;302(4):H964-72.
  236. Mentha RA, de Vries J, Simon PR, Fewquandie BN, Brady J, Ingram S. Bringing our voices into the research world: lessons from the Kanyini Vascular Collaboration. Med J Aust 2012;197(1):55-6. Comment.
  237. Mischak H, Ioannidis JP, Argiles A, Attwood TK, Bongcam-Rudloff E, Broenstrup M, Charonis A, Chrousos GP, Delles C, Dominiczak A, Dylag T, Ehrich J, Egido J, Findeisen P, Jankowski J, Johnson RW, Julien BA, Lankisch T, Leung HY, Maahs D, Magni F, Manns MP, Manolis E, Mayer G, Navis G, Novak J, Ortiz A, Persson F, Peter K, Riese HH, Rossing P, Sattar N, Spasovski G, Thongboonkerd V, Vanholder R, Schanstra JP, Vlahou A. Implementation of proteomic biomarkers: making it work. Eur J Clin Invest 2012;42(9):1027-36. Review.
  238. Moran LJ, Noakes M, Wittert GA, Clifton PM, Norman RJ. Weight loss and vascular inflammatory markers in overweight women with and without polycystic ovary syndrome. Reprod Biomed Online 2012;25(5):500-3.
  239. Moretti JL, Burke SL, Davern PJ, Evans RG, Lambert GW, Head GA. Renal sympathetic activation from long-term low-dose angiotensin II infusion in rabbits. J Hypertens 2012;30(3):551-60.
  240. Myers MG, Nelson MR, Head GA. Automated office blood pressure measurement for routine clinical practice. Med J Aust 2012;197(7):372-3. Review.
  241. Nestel P. Nutrition and metabolism: the changing face of the dairy-cardiovascular risk paradox. Curr Opin Lipidol 2012;23(1):1-3. Editorial.
  242. Nestel P, Hoang A, Sviridov D, Straznicky N. Cholesterol efflux from macrophages is influenced differentially by plasmas from overweight insulin-sensitive and -resistant subjects. Int J Obes 2012;36(3):407-13.
  243. Nestel PJ, Pally S, Macintosh GL, Greeve MA, Middleton S, Jowett J, Meikle PJ. Circulating inflammatory and atherogenic biomarkers are not increased following single meals of dairy foods. Eur J Clin Nutr 2012;66(1):25-31.
  244. Ng TW, Khan AA, Meikle PJ. Investigating the pathogenesis and risk of Type 2 diabetes: clinical applications of metabolomics. Clin Lipidol 2012;7(6):641-59. Review.
  245. Nicholls PK, Stanton PG, Chen JL, Olcorn JS, Haverfield JT, Qian H, Walton KL, Gregorevic P, Harrison CA. Activin signaling regulates sertoli cell differentiation and function. Endocrinology 2012;153(12):6065-77.
  246. O'Flaherty M, Allender S, Taylor R, Stevenson C, Peeters A, Capewell S. The decline in coronary heart disease mortality is slowing in young adults (Australia 1976-2006): a time trend analysis. Int J Cardiol 2012;158(2):193-8.
  247. Ogah OS, Okpechi I, Chukwuonye II, Akinyemi JO, Onwubere BJ, Falase AO, Stewart S, Sliwa K. Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: a review. World J Cardiol 2012;4(12):327-40. Review.
  248. Okabe J, Orlowski C, Balcerczyk A, Tikellis C, Thomas MC, Cooper ME, El-Osta A. Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells. Circ Res 2012;110(8):1067-76.
  249. Ooi EM, Ng TW, Watts GF, Chan DC, Barrett PH. Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome. J Lipid Res 2012;53(11):2443-9.
  250. Ott C, Schneider MP, Schlaich MP, Schmieder RE. Rosuvastatin improves pulse wave reflection by restoring endothelial function. Microvasc Res 2012;84(1):60-4.
  251. Owen N. Ambulatory monitoring and sedentary behaviour: a population-health perspective. Physiol Meas 2012;33(11):1801-10. Review.
  252. Owen N. Sedentary behavior: understanding and influencing adults' prolonged sitting time. Prev Med 2012;55(6):535-9. Review.
  253. Owen N. The emerging public-health science of sedentary time: what is the relevance to low and middle income countries? Brazil J Phys Activity Health 2012;17(6):457-60. Editorial.
  254. Packham DK, Alves TP, Dwyer JP, Atkins R, de Zeeuw D, Cooper M, Shahinfar S, Lewis JB, Lambers Heerspink HJ. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database. Am J Kidney Dis 2012;59(1):75-83.
  255. Packham DK, Wolfe R, Reutens AT, Berl T, Heerspink HL, Rohde R, Ivory S, Lewis J, Raz I, Wiegmann TB, Chan JC, de Zeeuw D, Lewis EJ, Atkins RC; Collaborative Study Group. Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy. J Am Soc Nephrol 2012;23(1):123-30.
  256. Palma-Rigo K, Bassi JK, Nguyen-Huu TP, Jackson KL, Davern PJ, Chen D, Elghozi JL, Thomas WG, Allen AM, Head GA. Angiotensin 1A receptors transfected into caudal ventrolateral medulla inhibit baroreflex gain and stress responses. Cardiovasc Res 2012;96(2):330-9.
  257. Parati G, Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J 2012;33(9):1058-66. Review.
  258. Patko Z, Csaszar A, Acsady G, Peter K, Schwarz M. Roles of Mac-1 and glycoprotein IIb/IIIa integrins in leukocyte-platelet aggregate formation: stabilization by Mac-1 and inhibition by GpIIb/IIIa blockers. Platelets 2012;23(5):368-75.
  259. Pearce KL, Noakes M, Wilson C, Clifton PM. Continuous glucose monitoring and cognitive performance in type 2 diabetes. Diabetes Technol Ther 2012;14(12):1126-33.
  260. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 2012;8(8):457-65. Review.
  261. Peeters A, Backholer K. Is the health burden associated with obesity changing? Am J Epidemiol 2012;176(10):840-5. Review.
  262. Peiris D, Brown A, Howard M, Rickards BA, Tonkin A, Ring I, Hayman N, Cass A. Building better systems of care for Aboriginal and Torres Strait Islander people: findings from the Kanyini health systems assessment. BMC Health Serv Res 2012;12:369.
  263. Peter K, Bobik A. HMGB1 signals danger in acute coronary syndrome: emergence of a new risk marker for cardiovascular death? Atherosclerosis 2012;221(2):317-8. Editorial.
  264. Poole RL, Leith DJ, Docherty LE, Shmela ME, Gicquel C, Splitt M, Temple IK, Mackay DJ. Beckwith-Wiedemann syndrome caused by maternally inherited mutation of an OCT-binding motif in the IGF2/H19-imprinting control region, ICR1. Eur J Hum Genet 2012;20(2):240-3.
  265. Pretorius S, Sliwa K, Ruf V, Walker K, Stewart S. Feeding the emergence of advanced heart disease in Soweto: a nutritional survey of black African patients with heart failure. Cardiovasc J Afr 2012;23(5):245-51.
  266. Rafehi H, El-Osta A, Karagiannis TC. Epigenetic mechanisms in the pathogenesis of diabetic foot ulcers. J Diabetes Complications 2012;26(6):554-61. Review.
  267. Rafehi H, Smith AJ, Balcerczyk A, Ziemann M, Ooi J, Loveridge SJ, Baker EK, El-Osta A, Karagiannis TC. Investigation into the biological properties of the olive polyphenol, hydroxytyrosol: mechanistic insights by genome-wide mRNA-Seq analysis. Genes Nutr 2012;7(2):343-55.
  268. Rafehi H, Ververis K, Balcerczyk A, Ziemann M, Ooi J, Hu S, Kwa FA, Loveridge SJ, Georgiadis GT, El-Osta A, Karagiannis TC. Investigation of the biological properties of Cinnulin PF in the context of diabetes: mechanistic insights by genome-wide mRNA-Seq analysis. Pathobiol Aging Age Relat Dis 2012;2:11905.
  269. Rafehi H, Ververis K, Karagiannis TC. Controversies surrounding the clinical potential of cinnamon for the management of diabetes. Diabetes Obes Metab 2012;14(6):493-9. Review.
  270. Rafehi H, Ververis K, Karagiannis TC. Mechanisms of action of phenolic compounds in olive. J Diet Suppl 2012;9(2):96-109. Review.
  271. Rajapakse NW, Kuruppu S, Hanchapola I, Venardos K, Mattson DL, Smith AI, Kaye DM, Evans RG. Evidence that renal arginine transport is impaired in spontaneously hypertensive rats. Am J Physiol Renal Physiol 2012;302(12):F1554-62.
  272. Randall DA, Jorm LR, Lujic S, O'Loughlin AJ, Churches TR, Haines MM, Eades SJ, Leyland AH. Mortality after admission for acute myocardial infarction in Aboriginal and non-Aboriginal people in New South Wales, Australia: a multilevel data linkage study. BMC Public Health 2012;12:281.
  273. Raz I, Amiel SA, Alberti G, Shehadeh N, Del Prato S, Zimmet P, Cefalu WT. Global call for free academic movement for international dialogue. Diabetes Care 2012;35(8):1631-2. Editorial.
  274. Reimann M, Hamer M, Schlaich M, Malan NT, Rüdiger H, Ziemssen T, Malan L. Autonomic responses to stress in Black versus Caucasian Africans: the SABPA Study. Psychophysiology 2012;49(4):454-61.
  275. Reimann M, Hamer M, Schlaich MP, Malan NT, Ruediger H, Ziemssen T, Malan L. Greater cardiovascular reactivity to a cold stimulus is due to higher cold pain perception in black Africans: the Sympathetic Activity and Ambulatory Blood Pressure in Africans (SABPA) study. J Hypertens 2012;30(12):2416-24.
  276. Reményi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K, Lawrenson J, Maguire G, Marijon E, Mirabel M, Mocumbi AO, Mota C, Paar J, Saxena A, Scheel J, Stirling J, Viali S, Balekundri VI, Wheaton G, Zühlke L, Carapetis J. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline. Nat Rev Cardiol 2012;9(5):297-309. Guidelines.
  277. Rémond MG, Atkinson D, White A, Hodder Y, Brown AD, Carapetis JR, Maguire GP. Rheumatic Fever Follow-Up Study (RhFFUS) protocol: a cohort study investigating the significance of minor echocardiographic abnormalities in Aboriginal Australian and Torres Strait Islander children. BMC Cardiovasc Disord 2012;12:111. Protocol.
  278. Reutens AT, Hutchinson R, Van Binh T, Cockram C, Deerochanawong C, Ho LT, Ji L, Khalid BA, Kong AP, Lim-Abrahan MA, Tan CE, Tjokroprawiro A, Yoon KH, Zimmet PZ, Shaw JE. The GIANT study, a cluster-randomised controlled trial of efficacy of education of doctors about type 2 diabetes mellitus management guidelines in primary care practice. Diabetes Res Clin Pract 2012;98(1):38-45.
  279. Ritchie RH, Love JE, Huynh K, Bernardo BC, Henstridge DC, Kiriazis H, Tham YK, Sapra G, Qin C, Cemerlang N, Boey EJ, Jandeleit-Dahm K, Du XJ, McMullen JR. Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes. Diabetologia 2012;55(12):3369-81.
  280. Rodd AL, Ververis K, Karagiannis TC. Safety and efficacy of pralatrexate in the management of relapsed or refractory peripheral T-cell lymphoma. Clin Med Insights Oncol 2012;6:305-14. Review.
  281. Ronaldson KJ, Fitzgerald PB, Taylor AJ, McNeil JJ. Continuation of clozapine following mild myocarditis. Aust N Z J Psychiatry 2012;46(9):910-1. Letter.
  282. Ronaldson KJ, Fitzgerald PB, Taylor AJ, McNeil JJ. Observations from 8 cases of clozapine rechallenge after development of myocarditis. J Clin Psychiatry 2012;73(2):252-4. Letter.
  283. Ronaldson KJ, Fitzgerald PB, Taylor AJ, Topliss DJ, McNeil JJ. Clozapine-induced myocarditis and baseline echocardiography. Aust N Z J Psychiatry 2012;46(10):1006-7. Author reply.
  284. Ronaldson KJ, Fitzgerald PB, Taylor AJ, Topliss DJ, Wolfe R, McNeil JJ. Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study. Schizophr Res 2012;141(2-3):173-8.
  285. Royce SG, Dang W, Yuan G, Tran J, El-Osta A, Karagiannis TC, Tang ML. Effects of the histone deacetylase inhibitor, trichostatin A, in a chronic allergic airways disease model in mice. Arch Immunol Ther Exp 2012;60(4):295-306.
  286. Royce SG, Karagiannis TC. Histone deacetylases and their role in asthma. J Asthma 2012;49(2):121-8.
  287. Royce SG, Ververis K, Karagiannis TC. Histone deacetylase inhibitors: can we consider potent anti-neoplastic agents for the treatment of asthma? Ann Clin Lab Sci 2012;42(3):338-45. Review.
  288. Ryan AT, Feinle-Bisset C, Kallas A, Wishart JM, Clifton PM, Horowitz M, Luscombe-Marsh ND. Intraduodenal protein modulates antropyloroduodenal motility, hormone release, glycemia, appetite, and energy intake in lean men. Am J Clin Nutr 2012;96(3):474-82.
  289. Sampson AK, Hilliard LM, Moritz KM, Thomas MC, Tikellis C, Widdop RE, Denton KM. The arterial depressor response to chronic low-dose angiotensin II infusion in female rats is estrogen dependent. Am J Physiol Regul Integr Comp Physiol 2012;302(1):R159-65.
  290. Sampson AK, Jennings GL, Chin-Dusting JP. Y are males so difficult to understand? A case where "X" does not mark the spot. Hypertension 2012;59(3):525-31. Review.
  291. Sasongko MB, Wong TY, Nguyen TT, Kawasaki R, Jenkins AJ, Shaw J, Robinson C, Wang JJ. Serum apolipoproteins are associated with systemic and retinal microvascular function in people with diabetes. Diabetes 2012;61(7):1785-92.
  292. Sasongko MB, Wong TY, Nguyen TT, Shaw JE, Jenkins AJ, Wang JJ. Novel versus traditional risk markers for diabetic retinopathy. Diabetologia 2012;55(3):666-70.
  293. Schlaich MP, Hering D, Esler MD. Catheter based radiofrequency ablation of renal nerves for the treatment of resistant hypertension. Ital J Med 2012;6(2):105-9. Review.
  294. Schlaich MP, Hering D, Sobotka P, Krum H, Lambert GW, Lambert E, Esler MD. Effects of renal denervation on sympathetic activation, blood pressure, and glucose metabolism in patients with resistant hypertension. Front Physiol 2012;3:10. Review.
  295. Schlaich MP, Hering D, Sobotka PA, Krum H, Esler MD. Renal denervation in human hypertension: mechanisms, current findings, and future prospects. Curr Hypertens Rep 2012;14(3):247-53. Review.
  296. Schmid E, Krajewski S, Bachmann D, Kurz J, Wendel HP, Rosenberger P, Balkau B, Peter K, Unertl K, Straub A. The volatile anesthetic sevoflurane inhibits activation of neutrophil granulocytes during simulated extracorporeal circulation. Int Immunopharmacol 2012;14(2):202-8.
  297. Schneider MP, Ott C, Ritt M, Raff U, Schlaich MP, Schmieder RE. Postchallenge hyperglycemia is closely related with early vascular damage in overweight and obese patients. J Hypertens 2012;30(1):147-52.
  298. Sedeek M, Montezano AC, Hebert RL, Gray SP, Di Marco E, Jha JC, Cooper ME, Jandeleit-Dahm K, Schiffrin EL, Wilkinson-Berka JL, Touyz RM. Oxidative stress, Nox isoforms and complications of diabetes-potential targets for novel therapies. J Cardiovasc Transl Res 2012;5(4):509-18. Review.
  299. Sharma A, Bernatchez PN, de Haan JB. Targeting endothelial dysfunction in vascular complications associated with diabetes. Int J Vasc Med 2012;2012:750126. Review.
  300. Shaw J. Diabetes: regional variation in lower limb amputation incidence. Nat Rev Endocrinol 2012;8(7):386-8. Review.
  301. Shill J, Mavoa H, Allender S, Lawrence M, Sacks G, Peeters A, Crammond B, Swinburn B. Government regulation to promote healthy food environments - a view from inside state governments. Obes Rev 2012;13(2):162-73. Review.
  302. Shill J, Mavoa H, Crammond B, Loff B, Peeters A, Lawrence M, Allender S, Sacks G, Swinburn BA. Regulation to create environments conducive to physical activity: understanding the barriers and facilitators at the Australian state government level. PLoS One 2012;7(9):e42831.
  303. Shimura H, Sugiyama T, Winkler E, Owen N. High neighborhood walkability mitigates declines in middle-to-older aged adults' walking for transport. J Phys Act Health 2012;9(7):1004-8.
  304. Siebel AL, Carey AL, Kingwell BA. Can exercise training rescue the adverse cardiometabolic effects of low birth weight and prematurity? Clin Exp Pharmacol Physiol 2012;39(11):944-57.
  305. Silver BJ, Knox J, Smith KS, Ward JS, Boyle J, Guy RJ, Kaldor J, Rumbold AR. Frequent occurrence of undiagnosed pelvic inflammatory disease in remote communities of central Australia. Med J Aust 2012;197(11):647-51.
  306. Slape CI, Saw J, Jowett JB, Aplan PD, Strasser A, Jane SM, Curtis DJ. Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome. Blood 2012;120(12):2475-83.
  307. Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M, Stewart S. Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort. Eur Heart J 2012;33(7):866-74.
  308. Sliwa K, Lyons JG, Carrington MJ, Lecour S, Marais AD, Raal FJ, Stewart S. Different lipid profiles according to ethnicity in the Heart of Soweto study cohort of de novo presentations of heart disease. Cardiovasc J Afr 2012;23(7):389-95.
  309. Smink PA, Bakker SJ, Laverman GD, Berl T, Cooper ME, de Zeeuw D, Lambers Heerspink HJ. An initial reduction in serum uric acid during angiotensin receptor blocker treatment is associated with cardiovascular protection: a post-hoc analysis of the RENAAL and IDNT trials. J Hypertens 2012;30(5):1022-8.
  310. Sobotka PA, Krum H, Böhm M, Francis DP, Schlaich MP. The role of renal denervation in the treatment of heart failure. Curr Cardiol Rep 2012;14(3):285-92. Review.
  311. Song X, Pitkäniemi J, Gao W, Heine RJ, Pyörälä K, Söderberg S, Stehouwer CD, Zethelius B, Tuomilehto J, Laatikainen T, Tabák AG, Qiao Q; DECODE Study Group. Relationship between body mass index and mortality among Europeans. Eur J Clin Nutr 2012;66(2):156-65.
  312. Soro-Paavonen A, Gordin D, Forsblom C, Rosengard-Barlund M, Waden J, Thorn L, Sandholm N, Thomas MC, Groop PH; on behalf of the FinnDiane Study Group. Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J Hypertens 2012;30(2):375-383.
  313. Soulimane S, Simon D, Shaw J, Witte D, Zimmet P, Vol S, Borch-Johnsen K, Magliano D, Vistisen D, Balkau B. HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R. Diabetes Res Clin Pract 2012;96(3):392-9.
  314. Sourris KC, Harcourt BE, Tang PH, Morley AL, Huynh K, Penfold SA, Coughlan MT, Cooper ME, Nguyen TV, Ritchie RH, Forbes JM. Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes. Free Radic Biol Med 2012;52(3):716-23.
  315. Stevenson CE, Mannan H, Peeters A, Walls H, Magliano DJ, Shaw JE, McNeil JJ. The effect of modifiable risk factors on geographic mortality differentials: a modelling study. BMC Public Health 2012;12:79.
  316. Stewart JM, Sanson-Fisher RW, Eades S, Fitzgerald M. The risk status, screening history and health concerns of Aboriginal and Torres Strait Islander people attending an Aboriginal Community Controlled Health Service. Drug Alcohol Rev 2012;31(5):617-24.
  317. Stewart S. Nurse-led care of heart failure: will it work in remote settings? Heart Lung Circ 2012;21(10):644-7. Review.
  318. Stewart S, Carrington MJ, Marwick TH, Davidson PM, Macdonald P, Horowitz JD, Krum H, Newton PJ, Reid C, Chan YK, Scuffham PA. Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trial. J Am Coll Cardiol 2012;60(14):1239-48.
  319. Stewart S, Carrington MJ, Pretorius S, Ogah OS, Blauwet L, Antras-Ferry J, Sliwa K. Elevated risk factors but low burden of heart disease in urban African primary care patients: a fundamental role for primary prevention. Int J Cardiol 2012;158(2):205-10.
  320. Stewart S, Carrington MJ, Swemmer CH, Anderson C, Kurstjens NP, Amerena J, Brown A, Burrell LM, de Looze FJ, Harris M, Hung J, Krum H, Nelson M, Schlaich M, Stocks NP, Jennings GL; on behalf of the VIPER-BP study investigators. Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial. Br Med J 2012;345:e7156.
  321. Stewart S, Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M. HIV and heart disease: a matter of time or an opportunity to prevent the inevitable? Eur Heart J 2012;eLetter 17 January. Author reply.
  322. Strang F, Scheichl A, Chen YC, Wang X, Htun NM, Bassler N, Eisenhardt SU, Habersberger J, Peter K. Amyloid plaques dissociate pentameric to monomeric C-reactive protein: a novel pathomechanism driving cortical inflammation in Alzheimer's disease? Brain Pathol 2012;22(3):337-46.
  323. Strange G, Playford D, Stewart S, Deague JA, Nelson H, Kent A, Gabbay E. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart 2012;98(24):1805-11.
  324. Straznicky NE, Eikelis N, Nestel PJ, Dixon JB, Dawood T, Grima MT, Sari CI, Schlaich MP, Esler MD, Tilbrook AJ, Lambert GW, Lambert EA. Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects. J Clin Endocrinol Metab 2012;97(2):605-13.
  325. Straznicky NE, Grima MT, Sari CI, Eikelis N, Lambert EA, Nestel PJ, Esler MD, Dixon JB, Chopra R, Tilbrook AJ, Schlaich MP, Lambert GW. Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61(10):2506-16.
  326. Straznicky NE, Lambert EA. Losing weight subconsciously. Australasian Science 2012;33(5):16-8. Review.
  327. Straznicky NE, Lambert EA, Grima MT, Eikelis N, Nestel PJ, Dawood T, Schlaich MP, Masuo K, Chopra R, Sari CI, Dixon JB, Tilbrook AJ, Lambert GW. The effects of dietary weight loss with or without exercise training on liver enzymes in obese metabolic syndrome subjects. Diabetes Obes Metab 2012;14(2):139-48.
  328. Stub D, Bernard S, Smith K, Bray JE, Cameron P, Duffy SJ, Kaye DM. Do we need cardiac arrest centres in Australia? Intern Med J 2012;42(11):1173-9. Review.
  329. Stub D, Smith K, Bernard S, Bray JE, Stephenson M, Cameron P, Meredith I, Kaye DM; AVOID Study. A randomized controlled trial of oxygen therapy in acute myocardial infarction Air Verses Oxygen in myocarDial infarction study (AVOID Study). Am Heart J 2012;163(3):339-45.
  330. Sugerman HJ, Blackstone RP, Dixon JB, Kral JG, Wolfe BM. Impact of bariatric surgery on health care utilization and costs among patients with diabetes. Med Care 2012;50(5):460; author reply 460-1. Comment.
  331. Sugiyama T, Merom D, van der Ploeg HP, Corpuz G, Bauman A, Owen N. Prolonged sitting in cars: prevalence, socio-demographic variations, and trends. Prev Med 2012;55(4):315-8.
  332. Sugiyama T, Neuhaus M, Cole R, Giles-Corti B, Owen N. Destination and route attributes associated with adults' walking: a review. Med Sci Sports Exerc 2012;44(7):1275-86. Review.
  333. Ta HT, Peter K, Hagemeyer CE. Enzymatic antibody tagging: toward a universal biocompatible targeting tool. Trends Cardiovasc Med 2012;22(4):105-11. Review.
  334. Tanamas SK, Wluka AE, Berry P, Menz HB, Strauss BJ, Davies-Tuck M, Proietto J, Dixon JB, Jones G, Cicuttini FM. Relationship between obesity and foot pain and its association with fat mass, fat distribution, and muscle mass. Arthritis Care Res 2012;64(2):262-8.
  335. Taylor AJ. Improving the odds in the evaluation of chest pain. J Am Coll Cardiol 2012;60(21):2216-7. Editorial.
  336. Teh AH, Symonds E, Bull C, Clifton P, Fenech M. The influence of folate and methionine on intestinal tumour development in the ApcMin/+ mouse model. Mutat Res 2012;751(1):64-75. Review.
  337. Teh AW, Kalman JM, Lee G, Medi C, Heck PM, Ling LH, Kumar S, Spence SJ, Morton JB, Kistler PM. Electroanatomic remodelling of the pulmonary veins associated with age. Europace 2012;14(1):46-51.
  338. Teh AW, Kistler PM, Lee G, Medi C, Heck PM, Spence SJ, Morton JB, Sanders P, Kalman JM. Long-term effects of catheter ablation for lone atrial fibrillation: Progressive atrial electroanatomic substrate remodeling despite successful ablation. Heart Rhythm 2012;9(4):473-80.
  339. Teh AW, Kistler PM, Lee G, Medi C, Heck PM, Spence SJ, Sparks PB, Morton JB, Kalman JM. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease. J Cardiovasc Electrophysiol 2012;23(3):232-8.
  340. Teichtahl AJ, Hanna F, Wluka AE, Urquhart DM, Wang Y, English DR, Giles GG, Cicuttini FM. A flatter proximal trochlear groove is associated with patella cartilage loss. Med Sci Sports Exerc 2012;44(3):496-500.
  341. Teng TH, Hung J, Knuiman M, Stewart S, Arnolda L, Jacobs I, Hobbs M, Sanfilippo F, Geelhoed E, Finn J. Trends in long-term cardiovascular mortality and morbidity in men and women with heart failure of ischemic versus non-ischemic aetiology in Western Australia between 1990 and 2005. Int J Cardiol 2012;158(3):405-10.
  342. Teperino R, Amann S, Bayer M, McGee SL, Loipetzberger A, Connor T, Jaeger C, Kammerer B, Winter L, Wiche G, Dalgaard K, Selvaraj M, Gaster M, Lee-Young RS, Febbraio MA, Knauf C, Cani PD, Aberger F, Penninger JM, Pospisilik JA, Esterbauer H. Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fat. Cell 2012;151(2):414-26.
  343. Thomas M. A preliminary evaluation of bardoxolone methyl for the treatment of diabetic nephropathy. Expert Opin Drug Metab Toxicol 2012;8(8):1015-22. Review.
  344. Thomas MC, Groop PH, Tryggvason K. Towards understanding the inherited susceptibility for nephropathy in diabetes. Curr Opin Nephrol Hypertens 2012;21(2):195-202. Review.
  345. Thomas MC, Jandeleit-Dahm KA, Tikellis C. The renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes. PPAR Res 2012;2012:456529. Review.
  346. Thomas MC, Moran JL, Harjutsalo V, Thorn L, Wadén J, Saraheimo M, Tolonen N, Leiviskä J, Jula A, Forsblom C, Groop PH; on behalf of the FinnDiane Study Group. Hyperfiltration in type 1 diabetes: does it exist and does it matter for nephropathy? Diabetologia 2012;55(5):1505-13.
  347. Thomson RL, Brinkworth GD, Noakes M, Clifton PM, Norman RJ, Buckley JD. The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome. Hum Reprod 2012;27(7):2169-76.
  348. Thorp AA, Healy GN, Winkler E, Clark BK, Gardiner PA, Owen N, Dunstan DW. Prolonged sedentary time and physical activity in workplace and non-work contexts: a cross-sectional study of office, customer service and call centre employees. Int J Behav Nutr Phys Act 2012;9:128.
  349. Tibazarwa K, Lee G, Mayosi B, Carrington M, Stewart S, Sliwa K. The 12-lead ECG in peripartum cardiomyopathy. Cardiovasc J Afr 2012;23(6):322-9.
  350. Tikellis C, Pickering R, Tsorotes D, Du XJ, Kiriazis H, Nguyen-Huu TP, Head GA, Cooper ME, Thomas MC. Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes. Clin Sci 2012;123(8):519-29.
  351. Tikellis C, Pickering RJ, Tsorotes D, Huet O, Chin-Dusting J, Cooper ME, Thomas MC. Activation of the renin-angiotensin system mediates the effects of dietary salt intake on atherogenesis in the apolipoprotein E knockout mouse. Hypertension 2012;60(1):98-105.
  352. Tikellis C, Thomas MC. Angiotensin converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept 2012;2012:256294. Review.
  353. Tomino Y, Cooper ME, Kurtz TW, Shimizu Y. Experimental models of type-2 diabetic nephropathy. Exp Diabetes Res 2012;2012:218917. Editorial.
  354. Vaisman BL, Andrews KL, Khong SM, Wood KC, Moore XL, Fu Y, Kepka-Lenhart DM, Morris SM Jr, Remaley AT, Chin-Dusting JP. Selective endothelial overexpression of arginase II induces endothelial dysfunction and hypertension and enhances atherosclerosis in mice. PLoS One 2012;7(7):e39487.
  355. Valenzuela M, Esler M, Ritchie K, Brodaty H. Antihypertensives for combating dementia? A perspective on candidate molecular mechanisms and population-based prevention. Transl Psychiatry 2012;2:e107. Review.
  356. van Dieren S, Kengne AP, Chalmers J, Beulens JW, Cooper ME, Grobbee DE, Harrap S, Mancia G, Neal B, Patel A, Poulter N, van der Schouw YT, Woodward M, Zoungas S. Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes. Diabetes Res Clin Pract 2012;98(1):83-90.
  357. Van Dyck D, Cerin E, Conway TL, De Bourdeaudhuij I, Owen N, Kerr J, Cardon G, Frank LD, Saelens BE, Sallis JF. Associations between perceived neighborhood environmental attributes and adults' sedentary behavior: findings from the USA, Australia and Belgium. Soc Sci Med 2012;74(9):1375-84.
  358. Veerman JL, Healy GN, Cobiac LJ, Vos T, Winkler EA, Owen N, Dunstan DW. Television viewing time and reduced life expectancy: a life table analysis. Br J Sports Med 2012;46(13):927-30.
  359. Ververis K, Karagiannis TC. An atlas of histone deacetylase expression in breast cancer: fluorescence methodology for comparative semi-quantitative analysis. Am J Transl Res 2012;4(1):24-43.
  360. Villani AM, Clifton PM, Keogh JB. Sodium intake and excretion in individuals with type 2 diabetes mellitus: a cross-sectional analysis of overweight and obese males and females in Australia. J Hum Nutr Diet 2012;25(2):129-39.
  361. Vink S, Jin AH, Poth KJ, Head GA, Alewood PF. Natriuretic peptide drug leads from snake venom. Toxicon 2012;59(4):434-45. Review.
  362. von Elverfeldt D, Meissner M, Peter K, Paul D, Meixner F, Neudorfer I, Merkle A, Harloff A, Zirlik A, Schöllhorn J, Markl M, Hennig J, Bode C, von zur Muhlen C. An approach towards molecular imaging of activated platelets allows imaging of symptomatic human carotid plaques in a new model of a tissue flow chamber. Contrast Media Mol Imaging 2012;7(2):204-13.
  363. von Elverfeldt D, von Zur Muhlen C, Wiens K, Neudorfer I, Zirlik A, Meissner M, Tilly P, Charles AL, Bode C, Peter K, Fabre JE. In vivo detection of activated platelets allows characterizing rupture of atherosclerotic plaques with molecular magnetic resonance imaging in mice. PLoS One 2012;7(9):e45008.
  364. von Zur Muhlen C, Schiffer E, Sackmann C, Zürbig P, Neudorfer I, Zirlik A, Htun N, Iphöfer A, Jänsch L, Mischak H, Bode C, Chen YC, Peter K. Urine proteome analysis reflects atherosclerotic disease in an ApoE-/- mouse model and allows the discovery of new candidate biomarkers in mouse and human atherosclerosis. Mol Cell Proteomics 2012;11(7):M111.013847.
  365. Walker KA, Cai X, Caruana G, Thomas MC, Bertram JF, Kett MM. High nephron endowment protects against salt-induced hypertension. Am J Physiol Renal Physiol 2012;303(2):F253-8.
  366. Walls HL, Magliano DJ, Stevenson CE, Backholer K, Mannan HR, Shaw JE, Peeters A. Projected progression of the prevalence of obesity in Australia. Obesity 2012;20(4):872-8.
  367. Walters TE, Kistler PM, Kalman JM. Radiofrequency ablation for atrial tachycardia and atrial flutter. Heart Lung Circ 2012;21(6-7):386-94.
  368. Walters TE, Kistler PM, Morton JB, Sparks PB, Halloran K, Kalman JM. Impact of collimation on radiation exposure during interventional electrophysiology. Europace 2012;14(11):1670-3.
  369. Wang B, Komers R, Carew R, Winbanks CE, Xu B, Herman-Edelstein M, Koh P, Thomas M, Jandeleit-Dahm K, Gregorevic P, Cooper ME, Kantharidis P. Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol 2012;23(2):252-65.
  370. Wang X, Hagemeyer CE, Hohmann JD, Leitner E, Armstrong PC, Jia F, Olschewski M, Needles A, Peter K, Ahrens I. Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice. Circulation 2012;125(25):3117-26.
  371. Warren SA, Briggs LE, Zeng H, Chuang J, Chang EI, Terada R, Li M, Swanson MS, Lecker SH, Willis MS, Spinale FG, Maupin-Furlowe J, McMullen JR, Moss RL, Kasahara H. Myosin light chain phosphorylation is critical for adaptation to cardiac stress. Circulation 2012;126(22):2575-88.
  372. Watson AM, Gray SP, Jiaze L, Soro-Paavonen A, Wong B, Cooper ME, Bierhaus A, Pickering R, Tikellis C, Tsorotes D, Thomas MC, Jandeleit-Dahm KA. Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice. Diabetes 2012;61(8):2105-13.
  373. Watt MJ, Barnett AC, Bruce CR, Schenk S, Horowitz JF, Hoy AJ. Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide. Diabetologia 2012;55(10):2741-6.
  374. Watts GF, Sullivan DR, van Bockxmeer FM, Poplawski N, Hamilton-Craig I, Clifton PM, O'Brien RC, Bishop W, George PM, Semsarian C, Tonkin A; for the Familial Hypercholesterolaemia Australasia Network. A new model of care for familial hypercholesterolaemia: what is the role of cardiology? Heart Lung Circ 2012;21(9):543-50. Review.
  375. Watts GF, Sullivan DR, van Bockxmeer FM, Poplawski N, Hamilton-Craig I, Clifton PM, O'Brien RC, George PM, Burnett JR. A model of care for familial hypercholesterolaemia: key role for clinical biochemistry. Clin Biochem Rev 2012;33(1):25-31. Review.
  376. Webster DE, Thomas MC. Post-translational modification of plant-made foreign proteins; glycosylation and beyond. Biotechnol Adv 2012;30(2):410-8. Review.
  377. Weeks KL, Gao X, Du XJ, Boey EJ, Matsumoto A, Bernardo BC, Kiriazis H, Cemerlang N, Tan JW, Tham YK, Franke TF, Qian H, Bogoyevitch MA, Woodcock EA, Febbraio MA, Gregorevic P, McMullen JR. Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction. Circ Heart Fail 2012;5(4):523-34.
  378. Whitham M, Chan MH, Pal M, Matthews VB, Prelovsek O, Lunke S, El-Osta A, Broenneke H, Alber J, Brüning JC, Wunderlich FT, Lancaster GI, Febbraio MA. Contraction-induced interleukin-6 gene transcription in skeletal muscle is regulated by c-Jun terminal kinase/activator protein-1. J Biol Chem 2012;287(14):10771-9.
  379. Whitty JA, Carrington MJ, Stewart S, Holliday J, Marwick TH, Scuffham PA. Patient preferences for the delivery of disease management in chronic heart failure: a qualitative study. J Cardiovasc Nurs 2012;27(3):201-7.
  380. Williams ED, Magliano DJ, Zimmet PZ, Kavanagh AM, Stevenson CE, Oldenburg BF, Shaw JE. Area-level socioeconomic status and incidence of abnormal glucose metabolism: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetes Care 2012;35(7):1455-61.
  381. Williams ED, Rawal L, Oldenburg BF, Renwick C, Shaw JE, Tapp RJ. Risk of cardiovascular and all-cause mortality: impact of impaired health-related functioning and diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetes Care 2012;35(5):1067-73.
  382. Winbanks CE, Beyer C, Qian H, Gregorevic P. Transduction of skeletal muscles with common reporter genes can promote muscle fiber degeneration and inflammation. PLoS One 2012;7(12):e51627.
  383. Winbanks CE, Weeks KL, Thomson RE, Sepulveda PV, Beyer C, Qian H, Chen JL, Allen JM, Lancaster GI, Febbraio MA, Harrison CA, McMullen JR, Chamberlain JS, Gregorevic P. Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin. J Cell Biol 2012;197(7):997-1008.
  384. Winkler EA, Gardiner PA, Clark BK, Matthews CE, Owen N, Healy GN. Identifying sedentary time using automated estimates of accelerometer wear time. Br J Sports Med 2012;46(6):436-42.
  385. Wolf D, Jehle F, Ortiz Rodriguez A, Dufner B, Hoppe N, Colberg C, Lozhkin A, Bassler N, Rupprecht B, Wiedemann A, Hilgendorf I, Stachon P, Willecke F, Febbraio M, Binder CJ, Bode C, Zirlik A, Peter K. CD40L deficiency attenuates diet-induced adipose tissue inflammation by impairing immune cell accumulation and production of pathogenic IgG-antibodies. PLoS One 2012;7(3):e33026.
  386. Wong E, Backholer K, Harding J, Gearon E, Stevenson C, Freak-Poli R, Peeters A. A systematic review and meta-analysis of diabetes and risk of physical disability and functional impairment - protocol. Syst Rev 2012;1:47. Protocol.
  387. Wong E, Stevenson C, Backholer K, Mannan H, Pasupathi K, Hodge A, Freak-Poli R, Peeters A. Adiposity measures as predictors of long-term physical disability. Ann Epidemiol 2012;22(10):710-6.
  388. Wu H, Ling LH, Lee G, Kistler PM. Successful catheter ablation of incessant atrial tachycardia in pregnancy using three-dimensional electroanatomical mapping with minimal radiation. Intern Med J 2012;42(6):709-12.
  389. Wycherley TP, Mohr P, Noakes M, Clifton PM, Brinkworth GD. Self-reported facilitators of, and impediments to maintenance of healthy lifestyle behaviours following a supervised research-based lifestyle intervention programme in patients with type 2 diabetes. Diabetic Med 2012;29(5):632-9.
  390. Wycherley TP, Moran LJ, Clifton PM, Noakes M, Brinkworth GD. Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2012;96(6):1281-98.
  391. Xu F, Wang Y, Ware RS, Tse LA, Dunstan DW, Liang Y, Wang Z, Hong X, Owen N. Physical activity, family history of diabetes and risk of developing hyperglycaemia and diabetes among adults in mainland China. Diabetic Med 2012;29(5):593-9.
  392. Yan M, Xu H, Waddell N, Shield-Artin K, Haviv I; kConFab authors, McKay MJ, Fox SB. Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers. Breast Cancer Res 2012;14(2):R69.
  393. Yang KC, Jay PY, McMullen JR, Nerbonne JM. Enhanced cardiac PI3Kα signalling mitigates arrhythmogenic electrical remodelling in pathological hypertrophy and heart failure. Cardiovasc Res 2012;93(2):252-62.
  394. Yap FY, Kantharidis P, Coughlan MT, Slattery R, Forbes JM. Advanced glycation end products as environmental risk factors for the development of type 1 diabetes. Curr Drug Targets 2012;25(2):129-39.
  395. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, Haffner S, Hamman RF, Ikram MK, Kayama T, Klein BE, Klein R, Krishnaiah S, Mayurasakorn K, O'Hare JP, Orchard TJ, Porta M, Rema M, Roy MS, Sharma T, Shaw J, Taylor H, Tielsch JM, Varma R, Wang JJ, Wang N, West S, Xu L, Yasuda M, Zhang X, Mitchell P, Wong TY; Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35(3):556-64.
  396. Zahnd G, Vray D, Sérusclat A, Alibay D, Bartold M, Brown A, Durand M, Jamieson LM, Kapellas K, Maple-Brown LJ, O'Dea K, Moulin P, Celermajer DS, Skilton MR. Longitudinal displacement of the carotid wall and cardiovascular risk factors: associations with aging, adiposity, blood pressure and periodontal disease independent of cross-sectional distensibility and intima-media thickness. Ultrasound Med Biol 2012;38(10):1705-15.
  397. Zimmet P, Alberti KGMM. Surgery or medical therapy for obese patients with type 2 diabetes? N Engl J Med 2012;366(17):1635-6. Editorial.
  398. Zimmet P, Bloomgarden ZT. How do we gauge the success of treatment of diabetes? J Diabetes 2012;4(3):193-4. Editorial.
  399. Zohdi V, Sutherland MR, Lim K, Gubhaju L, Zimanyi MA, Black MJ. Low birth weight due to intrauterine growth restriction and/or preterm birth: effects on nephron number and long-term renal health. Int J Nephrol 2012;2012:136942. Review.
  400. Zomer E, Owen A, Magliano DJ, Liew D, Reid CM. The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model. Br Med J 2012;344:e3657.
  401. Zomer E, Owen AJ, Magliano DJ, Reid CM. Statins for people at low risk of cardiovascular disease. Lancet 2012;380(9856):1817. Letter.
  402. Zoungas S, Chalmers J, Ninomiya T, Li Q, Cooper ME, Colagiuri S, Fulcher G, de Galan BE, Harrap S, Hamet P, Heller S, Macmahon S, Marre M, Poulter N, Travert F, Patel A, Neal B, Woodward M; for the ADVANCE Collaborative Group. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia 2012;55(3):636-643.

Book chapters

  1. Abbott AL. Proximal internal carotid artery stenosis: time to capitalize on current knowledge. In: Davies AH (ed, Fast Facts: Vascular and Endovascular Surgery Highlights 2011-12, Health Press, UK. 2012;Chapter 4, pp28-37.
  2. Esler M, Alvarenga M, Kaye D, Lambert G, Thompson J, Hastings J, Schwarz R, Morris M, Richards J. Panic disorder. In: Robertson D, Biaggioni I, Burnstock G, Low P, Paton J (eds), Primer on the Autonomic Nervous System, 3rd edition, Academic Press Inc, USA. 2012. Chapter 126, pp605-8.
  3. Gray S, DiMarco E, Jandeleit-Dahm K, Watson A. Novel treatments for diabetes-assoicated atheroslcerosis. In: Murakami E, Sakamoto H (eds), Atherosclerosis: Risk Factors, Prevention and Treatment, Nova Science, USA. 2012; Chapter 5, pp117-38.
  4. Lake NJ, Bozaoglu K, Khan AW, Jowett JBM. Approaches for dissection of the genetic basis of complex disease development in humans. In: Caliskan M (ed), Genetic Diversity in Microorganisms, InTech, Croatia. 2012; Chapter 13, pp309-39.
  5. Masuo K, Lambert GW. Cardiovascular and renal complications in obesity and obesity-related medical conditions: role of sympathetic nervous activity and insulin resistance. In: Arora C (ed), Insulin Resistance, InTech, Croatia. 2012; Chapter 7, pp159-88.
  6. Nestel PJ. Drugs that affect lipid metabolism. In: Aronson JK (ed), Side Effects of Drugs, Vol 34, Elsevier BV, The Netherlands. 2012; Chapter 44.
  7. Sourris KC, Forbes JM. Diabetic nephropathy: current and novel therapeutic approaches to prevent its development and progression. In: Sahay M (ed), Diseases of Renal Parenchyma, InTech, Croatia. 2012; Chapter 11, pp179-202.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more